Minimally invasive interval debulking surgery in ovarian neoplasm (MISSION trial–NCT02324595): a feasibility study-Reference-Cited by-同舟云学术

Minimally invasive interval debulking surgery in ovarian neoplasm (MISSION trial–NCT02324595): a feasibility study

Published:2016-04 Issue:4 Volume:214 Page:503.e1-503.e6
ISSN:0002-9378
Container-title:American Journal of Obstetrics and Gynecology
language:en
Short-container-title:American Journal of Obstetrics and Gynecology

Author:

Gueli Alletti Salvatore^ORCID,Bottoni Carolina,Fanfani Francesco,Gallotta Valerio,Chiantera Vito,Costantini Barbara,Cosentino Francesco,Ercoli Alfredo,Scambia Giovanni,Fagotti Anna

Publisher

Elsevier BV

Subject

Obstetrics and Gynaecology

Reference18 articles.

1. NCCN Clinical Practice Guidelines in Oncology. Ovarian cancer including fallopian tube cancer and primary peritoneal cancer. Version 1.2015. Available at: http://www.nccn.org/professionals/physician_gls/f_guidelines.asp. Accessed February 16, 2016.

2. Impact of interval debulking surgery on clinical outcome in primary unresectable FIGO stage IIIC ovarian cancer patients;Fanfani;Oncology,2003

3. Predicting surgical outcome in patients with International Federation of Gynecology and Obstetrics stage III or IV ovarian cancer using computed tomography: a systematic review of prediction models;Rutten;Int J Gynecol Cancer,2015

4. Prospective validation of a laparoscopic predictive model for optimal cytoreduction in advanced ovarian carcinoma;Fagotti;Am J Obstet Gynecol,2008

5. Laparoscopic staging of apparent early stage ovarian cancer: results of a large, retrospective, multi-institutional series;Gallotta;Gynecol Oncol,2014

Cited by 69 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Laparoscopic predictability of minimally invasive interval debulking in advanced ovarian cancer: The MIID-SOC trial;Gynecologic Oncology;2024-06

2. MIRRORS: a prospective cohort study assessing the feasibility of robotic interval debulking surgery for advanced-stage ovarian cancer;International Journal of Gynecologic Cancer;2024-04-01

3. Outcomes of minimal access cytoreductive surgery (M-CRS) and HIPEC/EPIC vs. open cytoreductive surgery (O-CRS) and HIPEC/EPIC in patients with peritoneal surface malignancies: a meta-analysis;Pleura and Peritoneum;2024-03-01

4. Case report: Minimally invasive primary debulking surgery for advanced stage epithelial ovarian cancer;Frontiers in Oncology;2024-02-02

5. Current treatment strategies for ovarian cancer in the East Asian Gynecologic Oncology Trial Group (EAGOT);Journal of Gynecologic Oncology;2024